NCT05439902View on ClinicalTrials.gov

Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 5, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Multiple SclerosisDysuriaLower Urinary Tract SymptomsVoiding DysfunctionUrinary Retention
Interventions
DRUG

Tamsulosin

One 0.4mg Tamsulosin capsule taken per day for 30 days

DRUG

Placebo

one placebo capsule per day for 30 days. with identical appearance (color and size) to the experimental drug, composed of microcrystalline cellulose

Trial Locations (1)

Unknown

RECRUITING

CHU de Nîmes, Nîmes

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER